LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW)

CUSIP: 55068A118

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
3,395,504
Share change
+2,639,025
Total reported value
$4,978,000
Price per share
$1.46
Number of holders
22
Value change
+$3,524,240
Number of buys
17
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 55068A118?
CUSIP 55068A118 identifies LUXAW - LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) as of Q1 2021

As of 31 Mar 2021, LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,395,504 shares. The largest 10 holders included Wolfswood Holdings, LLC, Empyrean Capital Partners, LP, MYDA Advisors LLC, Silver Rock Financial LP, Castle Creek Arbitrage, LLC, Balyasny Asset Management LLC, BBR PARTNERS, LLC, CNH PARTNERS LLC, Governors Lane LP, and Beryl Capital Management LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.